Data Integrity — ALCOA+ in Practice
Quality & Compliance
Data Integrity — ALCOA+ in Practice
Data integrity programs that meet FDA and MHRA expectations — built on ALCOA+ principles, implemented in your actual systems, and sustained by your team.
Data integrity has become one of FDA's highest enforcement priorities. Warning letters citing data integrity failures have been issued to pharmaceutical manufacturers, laboratory operations, and clinical research organizations worldwide — and the consequences are severe: import alerts, consent decrees, and facility shutdowns. Tomorrow's Crop builds data integrity programs that address the real risks in your operation — not just the theoretical ones — and that create a culture of data integrity that sustains compliance between inspections.
What We Do
A detailed breakdown of our capabilities in this practice area.
Data Integrity Gap Assessments
Structured gap assessments of your data integrity posture against FDA guidance, MHRA guidance, and ALCOA+ principles. We assess paper-based systems, electronic systems, hybrid systems, and laboratory instruments — and produce a prioritized remediation roadmap.
ALCOA+ Program Implementation
Implementation of ALCOA+ (Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, Available) data integrity principles across your quality and laboratory systems — in procedures, training, and daily practice.
Computer System Validation (CSV/CSA)
Computer system validation and computer software assurance programs for laboratory instruments, manufacturing systems, and quality management software — aligned with 21 CFR Part 11, EU Annex 11, and FDA's 2022 CSA guidance.
Audit Trail Review Programs
Design and implementation of audit trail review programs for electronic systems — defining review frequency, scope, and documentation requirements that meet regulatory expectations without creating unsustainable workloads.
Data Integrity Remediation
Comprehensive remediation programs for organizations that have received data integrity-related 483 observations or warning letters. We address root causes — not just symptoms — and implement sustainable corrections that restore regulatory confidence.
Laboratory Data Integrity
Specialized data integrity programs for quality control laboratories — covering chromatography data systems, LIMS, balance systems, spectroscopy instruments, and paper-based laboratory records.
Data Integrity Training
Role-based data integrity training for laboratory personnel, quality staff, and management — covering regulatory requirements, ALCOA+ principles, common failure modes, and individual responsibilities.
Data Governance Frameworks
Data governance frameworks that define data ownership, access controls, backup and recovery requirements, and data lifecycle management — providing the organizational structure that sustains data integrity over time.
How We Work
System Inventory & Risk Assessment
We inventory all systems that generate, process, or store GxP data — paper and electronic — and assess each against ALCOA+ principles and applicable regulatory requirements. We prioritize by risk to patient safety and regulatory compliance.
Gap Assessment
A detailed gap assessment of each system against regulatory expectations — identifying specific deficiencies in access controls, audit trails, backup procedures, training, and procedural controls.
Remediation Planning
A prioritized remediation plan that addresses identified gaps in a logical sequence — starting with the highest-risk systems and most critical deficiencies, and building toward a comprehensive data integrity program.
Implementation
We implement remediation actions — updating procedures, configuring system controls, validating systems, training personnel, and establishing ongoing monitoring programs.
Verification & Sustainability
We verify that implemented controls are functioning as intended and establish monitoring programs that provide ongoing assurance of data integrity — not just point-in-time compliance.
Outcomes You Can Expect
Why Tomorrow's Crop
Data integrity failures are among the most serious regulatory findings FDA issues — and the most difficult to remediate, because they often reflect cultural problems as much as technical ones. Our consultants have conducted data integrity assessments, managed remediation programs, and responded to data integrity-related warning letters inside regulated companies. We understand both the technical requirements and the organizational changes needed to build a genuine data integrity culture.
Deepen Your Knowledge
Insights, ready-to-use documents, and training programs related to this practice area.
Insights
- Data Integrity Remediation: Where to Start
- Understanding FDA Inspection Priorities in 2026
- Preparing Your Quality Unit for an FDA Inspection
Document Resources
- Laboratory Data Integrity & ALCOA+ ProgramTC-LAB-ADV-001
- OOS / OOT Laboratory Investigation SystemTC-LAB-FUND-004
- CAPA Foundation SOP & FormsTC-CAPA-FUND-001
Facing a time-sensitive regulatory matter?
FDA Inspection · Form FDA 483 · Warning Letter · Recall · Data Integrity
Ready to move forward?
Schedule a discovery call and let's define the right engagement for your organization.